Order Article Reprints

Chen Q-X, Zhou L, Long T, Qin D-L, Wang Y-L, Ye Y, Zhou X-G, Wu J-M, Wu A-G. Galangin Exhibits Neuroprotective Effects in 6-OHDA-Induced Models of Parkinson’s Disease via the Nrf2/Keap1 Pathway. Pharmaceuticals. 2022; 15(8):1014. https://doi.org/10.3390/ph15081014

Chen, Qiu-Xu, Ling Zhou, Tao Long, Da-Lian Qin, Yi-Ling Wang, Yun Ye, Xiao-Gang Zhou, Jian-Ming Wu, and An-Guo Wu. 2022. "Galangin Exhibits Neuroprotective Effects in 6-OHDA-Induced Models of Parkinson’s Disease via the Nrf2/Keap1 Pathway" Pharmaceuticals 15, no. 8: 1014. https://doi.org/10.3390/ph15081014

Chen, Q.-X., Zhou, L., Long, T., Qin, D.-L., Wang, Y.-L., Ye, Y., Zhou, X.-G., Wu, J.-M., & Wu, A.-G. (2022). Galangin Exhibits Neuroprotective Effects in 6-OHDA-Induced Models of Parkinson’s Disease via the Nrf2/Keap1 Pathway. Pharmaceuticals, 15(8), 1014. https://doi.org/10.3390/ph15081014